{
    "clinical_study": {
        "@rank": "125950", 
        "arm_group": [
            {
                "arm_group_label": "1. Carbon dioxide insufflation with BPS", 
                "description": "Both midazolam (0.05 mg/kg body weight; 1 mg if age[70 or ASA class III-IV) and fentanyl (50 lg; 25 lg if age[70 or ASA class III-IV) were given intravenously at the initiation of sedation. Thereafter, repeated doses of 10-20 mg propofol were administered to achieve a moderate level of sedation. Maintenance of sedation was also performed with repeated doses of 10-20 mg propofol."
            }, 
            {
                "arm_group_label": "2. Carbon dioxide insufflation with Propofol", 
                "description": "Sedation was induced by intravenous bolus injection of propofol (0.5 mg/kg body weight; 10 mg if age[70 or ASA class III-IV), followed by repeated doses of 10-20 mg propofol to induce sedation. Repeated doses of 10-20 mg propofol were then administered to maintain adequate sedation, according to the desired sedation depth and patient risk profile."
            }, 
            {
                "arm_group_label": "3. Air insufflation with BPS", 
                "description": "Both midazolam (0.05 mg/kg body weight; 1 mg if age[70 or ASA class III-IV) and fentanyl (50 lg; 25 lg if age[70 or ASA class III-IV) were given intravenously at the initiation of sedation. Thereafter, repeated doses of 10-20 mg propofol were administered to achieve a moderate level of sedation. Maintenance of sedation was also performed with repeated doses of 10-20 mg propofol."
            }, 
            {
                "arm_group_label": "4. Air insufflation with Propofol", 
                "description": "Sedation was induced by intravenous bolus injection of propofol (0.5 mg/kg body weight; 10 mg if age[70 or ASA class III-IV), followed by repeated doses of 10-20 mg propofol to induce sedation. Repeated doses of 10-20 mg propofol were then administered to maintain adequate sedation, according to the desired sedation depth and patient risk profile."
            }
        ], 
        "brief_summary": {
            "textblock": "Endoscopic retrograde cholangiopancreatography(ERCP) and related procedures can cause\n      abdominal pain and discomfort. Some clinical trials have indicated, using the visual\n      analogue scale (VAS) score, that CO2 insufflation during ERCP ameliorates the suffering of\n      patients without complications, compared with air insufflation. However, differences in\n      patient suffering between CO2 and air insufflation after ERCP depending on sedation\n      protocols have not been reported. We therefore planned prospective, double-blind,\n      randomized, controlled study with CO2 and air insufflation during ERCP depending on sedation\n      protocol."
        }, 
        "brief_title": "CO2 Versus O2 Insufflation During ERCP Depending on Sedation Protocols", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Satisfaction", 
            "Complication"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  candidates for therapeutic ERCP\n\n        Exclusion Criteria:\n\n          -  age<18 years\n\n          -  pregnant women\n\n          -  total gastrectomy\n\n          -  uncontrolled coagulopathy\n\n          -  American Society of Anesthesiologist(ASA) Class V\n\n          -  neurologic impairment\n\n          -  known allergy to the drugs used\n\n          -  history of complications with previous sedation, sedative\n\n          -  alcohol abuse\n\n          -  inability to provide informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The study had an 80% power to detect a 20% difference in PAIN score any two groups,\n        assuming 2-sided tests at a 5% significance level.Assuming a 10 % dropout rate, 220\n        patients were needed."
            }
        }, 
        "enrollment": {
            "#text": "210", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01761474", 
            "org_study_id": "ERCP-Sedation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Carbon dioxide insufflation", 
            "Air insufflatioin", 
            "ERCP", 
            "Sedation"
        ], 
        "lastchanged_date": "March 17, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cheonan", 
                    "country": "Korea, Republic of", 
                    "state": "Chungchungnam-do", 
                    "zip": "330-721"
                }, 
                "name": "Soon Chun Hyang University Cheonan Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "4", 
        "official_title": "Carbon Dioxide Insufflations vs. Air Insufflation in Therapeutic ERCP: A Randomized Double-blind Comparative Study Depending on Sedation Methods", 
        "overall_official": {
            "affiliation": "Soonchunhyang University School of Medicine", 
            "last_name": "Tae Hoon Lee, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Abdominal pain, discomfort, and gas accumulation", 
            "measure": "Sedation quality", 
            "safety_issue": "No", 
            "time_frame": "After patients' alertness (at least 10 minutes later), 3 hrs, and 24 hrs later"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761474"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Soon Chun Hyang University", 
            "investigator_full_name": "Tae Hoon Lee", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Procedure related complications; pancreatitis, bleeding, cholangitis, or perforation", 
                "measure": "Complications", 
                "safety_issue": "No", 
                "time_frame": "After completion of procedures (within 2 hrs) and 24 hrs later"
            }, 
            {
                "description": "Technical success or fail of procedure\nProcedure quality and satisfaction to patients and endoscopist", 
                "measure": "Procedure outcome", 
                "safety_issue": "No", 
                "time_frame": "After completion of procedure, within 2hrs"
            }
        ], 
        "source": "Soon Chun Hyang University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Soon Chun Hyang University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}